| Name | GSK-2018682 |
|---|---|
| Synonyms |
CPD1224
D1224 1H-Indole-1-butanoic acid, 4-[5-[5-chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl] GSK2018682, 10 mM in DMSO 4-(4-{5-[5-chloro-6-(propan-2-yloxy)pyridin-3-yl]-1,2,4-oxadiazol-3-yl}-1H-indol-1-yl)butanoic acid 4-[5-[5-Chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-1H-indole-1-butanoic acid LPL Rector,Inhibitor,inhibit,Lysophospholipid Rector,GSK-2018682,GSK 2018682,GSK S1PR-1 agonist GS2018682 GSK2018682 |
| Description | GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4. GSK2018682 is used in the research of multiple sclerosis. |
|---|---|
| Related Catalog | |
| Target |
pEC50: 7.7 (S1P1 receptor), 7.2 (S1P5 receptor)[1] |
| In Vitro | GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4[1]. |
| References |
| Molecular Formula | C22H21ClN4O4 |
|---|---|
| Molecular Weight | 440.88 |
| Storage condition | 2-8℃ |